21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#8702ANTIVIRAL AGENT
#8703METHOD FOR PREPARING POLYDOPAMINE NANOMOTOR USING UREASE, AND USE OF SAME
#8704C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#8705METHOD OF TREATING ORAL PAIN WITH AN EFFERVESCING COMPOSITION
#8706ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS
#8707IRAK DEGRADERS AND USES THEREOF
#8708COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION
#8709HEPATOPANCREATIC NECROSIS DISEASE SIGNATURES AND USES THEREOF
#8710Immunomodulatory RNA
#8711N-PYRIDINYL ACETAMIDE DERIVATIVES AS WNT SIGNALLING PATHWAY INHIBITORS
#8712Compositions comprising cannabinoids and methods of use
#8713REGENERATIVE NONSTEROIDAL ANTI-INFLAMMATORY COMPOSITIONS, METHODS OF PRODUCTION, AND METHODS OF USE THEREOF
#8714Method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes
#8715USE OF QUINAZOLINE-BASED TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCERS WITH NRG1 FUSIONS
#8716RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF
#8717Treatment for coronavirus infection and associated cytokine toxicity
#8718METHODS AND COMPOSITIONS FOR TREATING ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS SYNDROME
#8719ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
#8720COMPOSITIONS AND METHODS FOR INHIBITION OF MICA/B SHEDDING
#8721Stat degraders and uses thereof
#8722ANTIVIRAL AGENTS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION
#87233,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors
#8724VARIANTS OF SAC7D AND THEIR USE IN CANCER THERAPY
#8725LIVER-SPECIFIC CONSTRUCTS, FACTOR VIII EXPRESSION CASSETTES AND METHODS OF USE THEREOF
#8726ASTROTACTIN1-BASED COMPOSITIONS AND PHARMACEUTICAL FORMULATIONS
#8727ANTIGEN SPECIFIC EPITOPE BASED ANTI-INFECTIVE VACCINES
#8728PEPTIDOMIMETIC MACROCYCLES
#8729EGFR INHIBITION TRIGGERS AN ADAPTIVE RESPONSE BY CO-OPTING ANTIVIRAL SIGNALING PATHWAYS IN LUNG CANCER
#8730MATERIALS AND METHODS FOR IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT-TARGETED CANCER THERAPY
#8731Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
#8732Adenosine A2A agonists for the treatment of cytokine storm syndrome
#8733OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
#8734Enhanced delivery of antioxidants for treatment of central nervous system disorders involving oxidative stress
#8735THERAPEUTIC USE OF LONG-ACTING CONJUGATE OF TRIPLE AGONIST HAVING ACTIVITIES TO ALL OF GLUCAGON/GLP-1/GIP RECEPTORS FOR LUNG DISEASE
#8736Bispecific antigen binding constructs targeting HER2
#8737PRC1 INHIBITORS AND METHODS OF TREATMENT THEREWITH
#8738SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS WEE1 INHIBITORS
#8739ESKETAMINE FOR THE TREATMENT OF DEPRESSION
#8740SMALL MOLECULE INHIBITORS OF ULK1
#8741DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER
#8742Immunomodulator compounds
#8743PYRAZOLOTRIAZINES
#8744Pro-cyclic dinucleotides and pro-cyclic dinucleotide conjugates for cytokine induction
#8745Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
#8746METHODS OF TREATING COVID-19 WITH RIFAXIMIN
#8747Tumor Homing Statin Derivatives
#8748Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof
#8749Compounds And Compositions As Protein Kinase Inhibitors
#8750METHOD OF TREATING CNS DISORDERS WITH NEUROSTEROIDS AND GABAERGIC COMPOUNDS
#8751Threonate Compounds and Methods of Use Thereof
#8752INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR MODULATING HEMATOPOIETIC STEM CELLS AND HEMATOPOIESIS
#8753PARAXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF
#8754Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
#8755Pemafibrate dosing regimens
#8756COMPOSITIONS AND METHODS FOR TREATING ACNE VULGARIS
#8757D glutamate polyglutamated antifolates and uses thereof
#8758TREATMENT OF PAIN AND VASOCONSTRICTION
#8759ANTIVIRAL HETEROCYCLIC COMPOUNDS
#8760PEPTIDES AND PHARMACEUTICAL, NUTRACEUTICAL OR VETERINARY COMPOSITIONS FOR HAIR LOSS PREVENTION AND/OR TREATMENT
#8761Pyrazole derivatives with anticancer activity
#8762PSILOCYBIN AND PSILOCIN CONTAINING COMPOSITIONS AND METHODS OF USING AND MAKING THE SAME
#8763RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF TUBERCULOSIS
#8764TERT IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME
#8765Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
#8766THERAPEUTIC RNA FOR PROSTATE CANCER
#8767NEW THERAPEUTIC USE OF ANAKINRA FOR COVID-19
#8768Composition for Use in the Prophylaxis and Treatment of Viral Infections of the Asfarviridae Family
#8769Sublingual Delivery for Mitigation of Side Effects Associated with Zicronapine
#8770COMPOSITIONS AND METHODS FOR MODULATING FORKHEAD BOX P3 (FOXP3) GENE EXPRESSION
#8771SYNTHETIC PROCESSES AND INTERMEDIATES
#8772Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease
#8773ANHYDROUS COMPOSITIONS OF EGFR INHIBITORS AND METHODS OF USE
#8774Compositions and methods for treating CNS disorders
#8775Methods for validating an apparatus for producing nanoparticles
#8776SSTR5 ANTAGONISTS
#87775-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR TREATMENT OF ACUTE LUNG INJURY
#8778TREATMENT OF LEUKEMIAS AND LYMPHOMAS WITH COMBINATIONS OF BCL-2 INHIBITORS AND PLK1 INHIBITORS
#8779NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#8780METHODS FOR CANCER TREATMENT
#8781GLYCAN PREPARATIONS FOR THE TREATMENT OF INFECTION
#8782Compounds and compositions for inducing chondrogenesis
#8783Pentagalloyl Glucose Derived from Schinus Plants and Methods of Use
#8784IL-1 Binding Proteins
#8785TREATMENT OF CANCER IN PATIENTS WITH SOLUBLE FR-ALPHA
#8786Crystalline norpsilocin compounds
#8787Substituted macrocyclic indole derivatives
#8788MARINE EXTRACT COMPOSITIONS AND METHODS OF USE
#8789Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis
#8790ANTIMALARIAL COMPOSITIONS AND USES THEREOF
#8791COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A PD-1 PATHWAY INHIBITOR, AND AN IMMUNOTHERAPEUTIC AGENT
#8792STABLE FORMULATIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME
#8793Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease
#8794METHODS AND COMPOSITIONS FOR THE DELIVERY OF MODIFIED LYMPHOCYTE AGGREGATES
#8795MITIGATION OF EPILEPTIC SEIZURES BY COMBINATION THERAPY USING BENZODIAZEPINES AND NEUROSTEROIDS
#8796TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS
#8797Method of Treating Diseases
#8798HEPARIN AND N-ACETYLCYSTEINE FOR THE TREATMENT OF A RESPIRATORY VIRUS
#8799VECTOR FOR CANCER TREATMENT
#8800COMPOSITIONS FOR TREATMENT OF PSORIASIS OF THE SCALP
#8801METHODS FOR THE TREATMENT OF HEADACHE DISORDERS
#8802Isofagomine salts, methods of use and formulations
#88031,2,4-Oxadiazole and Thiadiazole Compounds as Immunomodulators
#8804ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE
#8805PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT)
#8806THERAPEUTIC AGENT FOR TAUOPATHIES
#8807REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS
#8808PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR
#8809HUMAN TARGETS
#8810Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome
#8811Conditionally Active Anti-Her2 Antibodies, Antibody Fragments Their Immunoconjugates And Uses Thereof
#8812METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY
#8813METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME
#8814SUBSTITUTED BICYCLIC AND TRICYCLIC UREAS AND AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME
#8815INJECTABLE COMPOSITION FOR SKIN AND SOFT TISSUE AUGMENTATION
#8816Antiviral heterocyclic compounds
#8817OXALAMIDE SUBSTITUTED HETEROCYCLIC COMPOUNDS AS MODULATORS OF THE ARYL HYDROCARBON RECEPTOR (AHR)
#8818METHODS OF ADMINISTERING ANTI-OX40 ANTIBODIES
#8819NITRIC OXIDE-RELEASING ANTIBACTERIAL COMPOUNDS, FORMULATIONS, AND METHODS PERTAINING THERETO
#8820CXCL8 (INTERLEUKIN-8) ACTIVITY INHIBITOR AND CORTICOSTEROID COMBINATION AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#8821HEPATITIS B CAPSID ASSEMBLY MODULATORS
#8822METHODS OF TREATING IATROGENIC AUTOIMMUNE COLITIS
#8823Heterocyclic GLP-1 agonists
#8824METHOD OF ENHANCING IMMUNOTHERAPY USING ER STRESS PATHWAY INHIBITORS
#8825METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT
#8826METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING FIBROSIS RESULTING FROM A CORONAVIRUS INFECTION
#8827Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)
#8828ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES AND METHODS OF USE
#8829METHODS OF TREATING CANCER
#8830BIFIDOBACTERIUM LONGUM
#8831METHOD FOR TREATING CANCER USING A COMBINATION OF DNA DAMAGING AGENTS AND ATR INHIBITORS
#8832NOVEL PqsR INVERSE AGONISTS
#8833A BACTERIAL COMPOSITION FOR THE TREATMENT OF CANCER
#8834METHODS OF TREATING PARKINSON'S DISEASE
#8835sGC STIMULATORS
#8836COMBINATION DRUG THERAPIES FOR CNS DISORDERS
#8837ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS
#8838MESENCHYMAL STROMAL CELLS AND EXTRACELLULAR VESICLES FOR TREATING VIRAL INFECTIONS, INFLAMMATION, AND TISSUE FIBROSIS
#8839DIRECT DELIVERY OF ANTIOXIDANTS TO THE GUT
#8840Dry powder foamable formulations for delivery of medicaments through the mucosa
#8841Nanoparticle Modification of Human Adipose-Derived Mesenchymal Stem Cells for Treating Brain Cancer and Other Neurological Diseases
#8842PATCH PREPARATION
#8843Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
#8844COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH
#8845METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER
#8846BORTEZOMIB COMPOSITIONS
#8847METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#8848TNFa SIGNALING TRIGGERS TUMOR-PROMOTING INFLAMMATION THAT CAN BE TARGETED TO THERAPY
#8849MATERIALS AND METHODS FOR THE TREATMENT OF GAUCHER DISEASE
#8850Combination therapies and methods of use thereof for treating cancer
#8851EBNA1 inhibitor crystalline forms, and methods of preparing and using same
#8852METHODS AND USE FOR BIOENGINEERING ENUCLEATED CELLS
#8853METHODS, DEVICES, AND COMPOSITIONS FOR LESION REPAIR AND PREVENTION
#8854MULTIFUNCTIONAL MOLECULES THAT BIND TO CD33 AND USES THEREOF
#8855POLYMER MEDICAMENT FOR TREATING HYPERKALEMIA AND PREPARATION METHOD THEREOF
#8856COMPOUNDS AND METHODS FOR SUPPRESSING AN IMMUNE RESPONSE TO SUBSTANCES CONTAINING POLYETHYLENE GLYCOL
#8857Peptide vaccines
#8858CYCLIC COMPOUNDS AND METHODS OF USING SAME
#8859Immunomodulators
#8860AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE 2
#8861METHODS OF USING IL-33 PROTEIN IN TREATING CANCERS
#8862GINSENOSIDE M1 AS A MODULATOR OF ANGIOTENSIN REGULATING ENZYMES AND ITS USE FOR TREATING DISEASES OR CONDITIONS INCLUDING SYMPTOMS CAUSED BY CORONAVIRUS
#8863TRIAZOLO[4,5-D] PYRAMIDINE DERIVATIVES AND THEIR USE AS PURINE RECEPTOR ANTAGONISTS
#8864COVALENT RAS INHIBITORS AND USES THEREOF
#8865CANCER IMMUNOTHERAPY USING TRANSFUSIONS OF ALLOGENEIC, TUMOR-SPECIFIC CD4+ T CELLS
#8866MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#8867METHODS OF TREATING AND PREVENTING ALLOANTIBODY DRIVEN CHRONIC GRAFT VERSUS HOST DISEASE
#8868Methods and composition for induction of immune response
#8869PHYSICS-DRIVEN DISCOVERY OF NOVEL SMALL THERAPEUTIC COMPOUNDS FOR USE AS A BCL-2 INHIBITOR
#8870MACROCYCLIC ULK1/2 INHIBITORS
#8871Composition for preventing or treating TNF-related diseases, containing novel derivative as active ingredient, and method for inhibiting TNF activity by using same
#8872COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF IRAK-4
#8873RADIOLABELED PEPTIDES FOR NON-INVASIVE DIAGNOSIS AND TREATMENT OF CXCR4 EXPRESSING TUMORS
#8874COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY AND DEGENERATIVE DISORDER
#8875ANTIBODY DRUG CONJUGATE FOR ANTI-INFLAMMATORY APPLICATIONS
#8876HEPATITIS C VIRUS NS3/4A PROTEASE INHIBITORS
#8877DRG-MDM2-6 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR
#8878Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
#8879SCUTELLARIAE RADIX COMPOUNDS AND USE THEREOF FOR INHIBITING OXIDATIVE PHOSPHORYLATION PATHWAY OF MITOCHONDRIA
#8880Bi-functional Molecules to Degrade Circulating Proteins
#8881COMPOSITIONS AND METHODS FOR THE TREATMENT OF BRONCHOPULMONARY DYSPLASIA (BPD) AND BPD-ASSOCIATED PULMONARY HYPERTENSION
#8882Oral product
#8883METHODS OF INCREASING CELL PHAGOCYTOSIS
#8884E-selectin antagonist compounds, compositions, and methods of use
#8885Glycine receptor modulators and methods of use
#8886METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHOROIDAL NEOVASCULARISATION
#8887Indazole based compounds and associated methods of use
#8888METHODS OF TREATING AND PREVENTING GRAFT VERSUS HOST DISEASE
#8889Cannabinoids for use in suppressing cancer stem cells
#8890Lymphocyte Population and Methods for Producing Same
#8891PHARMACEUTICAL COMPOSITION FOR INHIBITING INFLAMMATORY RESPONSE COMPRISING HYDROXYUREA
#8892Crystalline forms of ALDH2 modulators
#8893NOVEL SUBTITUTED SULFONYLUREA AND SULFOXIMINEUREA DERIVATIVES
#8894BERBERINE COMPOUNDS, BERBERINE COMPOSITIONS, AND METHODS FOR ADMINISTRATION THEREOF
#8895PARASITE CONTROL IN RUMINANTS
#8896COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE, MYODEGENERATIVE, AND LYSOSOMAL STORAGE DISORDERS
#8897COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES
#8898Methods and compounds for the treatment or prevention of hypercytokinemia and severe influenza
#8899S1P RECEPTOR MODULATORS
#8900COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS
#8901Charged ion channel blockers and methods for use
#8902SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF TREATING REFRACTIVE OCULAR DISORDERS
#8903COMBINATION THERAPY USING INHIBITORS OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15) AND IMMUNE CHECKPOINT BLOCKERS
#8904A NOVEL MAO-B INHIBITOR DRG-MAOB-1 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES
#8905Methods of treating cancers having a BRCA1 and/or BRCA2 mutation(s)
#8906THERAPEUTIC USE OF P75NTR NEUROTROPHIN BINDING PROTEIN
#8907CHANGING COGNITIVE FUNCTION WITH FENFLURAMINE
#8908USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION
#8909COMPOSITIONS AND METHODS OF MODULATING S-NITROSYLATION
#8910METHODS FOR WOUND HEALING
#8911THERAPEUTIC DELIVERY OF LOCKED NUCLEIC ACID CONJUGATED ANTISENSE MIR-1
#8912DENDRIMER COMPOSITIONS AND THEIR USE IN TREATMENT OF DISEASES OF THE EYE
#8913Compositions comprising nanoparticles, method of making and uses thereof
#8914RADIOCONJUGATES TARGETING CD33 IN THE TREATMENT OF CANCERS
#8915DIROFILARIA VOLATILE ORGANIC COMPOUND SIGNATURES AND USES THEREOF
#8916PHARMACEUTICAL COMPOSITIONS COMPRISING DASATINIB ANHYDROUS AND USES THEREOF
#8917Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
#8918Tesofensine and beta blocker combination formulations
#8919HUMAN 4-1BB AGONIST ANTIBODIES AND METHODS OF USE THEREOF
#8920Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
#8921SUBSTANCE DELIVERY CARRIER AND COMPOSITION
#8922COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE RESPONSE
#8923COMPOUNDS THAT MODULATE ANTI-TUMOR IMMUNITY AND METHODS OF DOING THE SAME
#8924INTERMITTENT DOSING OF MDM2 INHIBITOR
#8925COMPOSITIONS AND METHODS FOR TREATING CANCER AND TUMOR
#8926Therapeutic composition and methods
#8927Crystalline forms of tenofovir alafenamide
#8928PHARMACEUTICAL PACKAGE FOR OPHTHALMIC FORMULATIONS
#8929Methods of treating hepatic encephalopathy
#8930METHODS OF TREATING OR PREVENTING SERIOUS SYMPTOMS FROM COVID-19 INFECTION
#8931SUSTAINED IMMUNOTHERAPY
#8932Methods for treating hypertension using an anti-BMP10 monoclonal antibody or fragment thereof
#8933NATURAL COMPOSITION BASED ON POLYMERS TO BE ELECTROSPUN, AND METHOD TO PREPARE THE SAME
#8934METHODS OF INHIBITING TUMOR METASTASIS
#8935SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS
#8936Bacterial Biomarker
#8937Compounds with Antimicrobial Properties
#8938Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
#8939Vaccines against hepatitis B virus
#8940TREATMENT OF PREMATURE BIRTH COMPLICATIONS
#8941IMPROVED ANTI-SENESCENCE COMPOUNDS AND USES THEREOF
#8942HEMP EXTRACT FOR TREATMENT OF PAIN, CANCER AND EPILEPSY IN ANIMALS
#8943Inhibitors of peptidylarginine deiminases
#8944MUSCARINIC ACETYLCHOLINE M1 RECEPTOR ANTAGONISTS
#8945PRODUCTS AND COMPOSITIONS
#8946USE OF DOXYCYCLINE, RESVERATROL, IVERMECTIN, AND RELATED CHEMICALLY MODIFIED COMPOUNDS TO TREAT OR PREVENT VIRAL INFECTIONS
#8947METHODS OF TREATING CANCER PATIENTS WITH FARNESYLTRANSFERASE INHIBITORS
#8948Fused ring heteroaryl compounds and use thereof
#8949TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS) PRODUCED BY HUMAN NEURAL OR GLIAL CELLS
#8950BIOAVAILABLE POLYAMINES
#8951NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#8952USE OF BMP INHIBITORS IN THE TREATMENT OF MOLAR PREGNANCY
#8953A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF A CANCER
#8954A NOVEL SELECTIVE MAO-B INHIBITOR DRG-MAOB-2 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES
#8955Drug mixing and delivery system and method
#8956Polyethylene glycol conjugate medicament, preparation method therefor and use thereof
#8957ISOTOPES OF ALPHA KETOGLUTARATE AND RELATED COMPOUNDS AND THEIR USE IN HYPERPOLARIZED IMAGING
#8958Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
#8959COMBINATIONS
#8960PARASITICIDAL COMPOSITIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF
#8961TREATMENT OF CNS CONDITIONS
#8962PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
#8963SMARCA DEGRADERS AND USES THEREOF
#8964METHODS OF USING EHMT2 INHIBITORS
#8965Agents and Methods for the Prevention or Treatment of H. Pylori Infections
#8966POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
#8967USE OF A SOLUBLE GUANYLATE CYCLASE (sGC) STIMULATOR OR OF A COMBINATION OF A sGC STIMULATOR AND AN sGC ACTIVATOR FOR CONDITIONS WHEREIN THE HEME GROUP OF sGC IS OXIDIZED OR WHEREIN sGC IS DEFICIENT IN HEME
#8968COMPOSITION OF SUSPOEMULSION FORMULATION OF ANTHELMINTIC DRUGS WITH ESSENTIAL OILS FOR NASO-PULMONARY ADMINISTRATION
#8969Benzodiazepine derivatives as RSV inhibitors
#8970ANTI-TUMORAL COMPOUND AND RELATIVE PRODUCTION PROCESS
#8971IMIDAZO[1,2-a]PYRIDINYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE
#8972COMPOSITIONS AND METHODS FOR THE TREATMENT OF PANCREATIC CANCER
#8973NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#8974DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR
#8975GLUCOPYRANOSYL DERIVATIVES AND THEIR USES
#8976Topical compositions and methods for treating psoriasis
#8977TELOMERE LENGTH MODULATION USING FIBROBLASTS
#8978Stable silk protein fragment compositions
#8979METHODS AND COMPOSITIONS FOR TREATING CANCER WITH IMMUNE CELLS
#8980Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
#8981PDAC TREATMENT REGIMEN
#8982COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH cGAS
#8983Adsorptive Radiocontrast Constructs And Uses Thereof
#8984GLUCOSE UPTAKE INHIBITORS AND USES THEREOF
#8985ACSS2 INHIBITORS AND METHODS OF USE THEREOF
#8986METHOD
#8987METHOD AND DRUG FOR PREVENTING AND TREATING MULTIPLE SCLEROSIS
#8988Immunomodulatory compositions and methods of use thereof
#8989EXTRACELLULAR VESICLE AND USE THEREOF IN SKIN PRODUCTS
#8990Compositions comprising at least one n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
#8991COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR AND ASSOCIATED METHODS OF USE
#8992VACCINE COMPRISING EPITOPE OF HEAT SHOCK PROTEIN, AND USE THEREOF
#8993STAT degraders and uses thereof
#8994METHODS OF TREATING OR PREVENTING SERIOUS SYMPTOMS FROM COVID-19 INFECTION
#8995SUBSTITUTED CYCLOPROPYL-2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME
#8996ELECTRONIC VAPOR LIQUID COMPOSITION AND METHOD OF USE
#8997Formulations, methods, and systems for treating genitourinary conditions
#8998METHODS FOR TREATING CANCER WITH A WEE1 INHIBITOR
#8999Integration of tumor characteristics with breast cancer index
#9000FILM-COATED GRANULE, PHARMACEUTICAL PREPARATION CONTAINING THE SAME, AND MANUFACTURING METHODS THEREOF